These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21480639)

  • 1. Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration.
    Date AA; Nagarsenker MS; Patere S; Dhawan V; Gude RP; Hassan PA; Aswal V; Steiniger F; Thamm J; Fahr A
    Mol Pharm; 2011 Jun; 8(3):716-26. PubMed ID: 21480639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation.
    Date AA; Srivastava D; Nagarsenker MS; Mulherkar R; Panicker L; Aswal V; Hassan PA; Steiniger F; Thamm J; Fahr A
    Nanomedicine (Lond); 2011 Oct; 6(8):1309-25. PubMed ID: 22026377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability.
    Peng Q; Zhang ZR; Sun X; Zuo J; Zhao D; Gong T
    Mol Pharm; 2010 Apr; 7(2):565-75. PubMed ID: 20166756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro-in vivo advantage.
    Jain AS; Shah SM; Nagarsenker MS; Nikam Y; Gude RP; Steiniger F; Thamm J; Fahr A
    J Biomed Nanotechnol; 2013 Jul; 9(7):1230-40. PubMed ID: 23909137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of formulation parameters on self-assembled liposomes (LeciPlex® III): A detailed investigation.
    Katawale S; Tank S; Dhaygude H; Holm R; Shah S; Shinde U; Shidhaye S; Aswal V; Kumar S; Nagarsenker M
    Int J Pharm; 2024 May; 657():124147. PubMed ID: 38657715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers.
    Liu L; Tang Y; Gao C; Li Y; Chen S; Xiong T; Li J; Du M; Gong Z; Chen H; Liu L; Yao P
    Colloids Surf B Biointerfaces; 2014 Mar; 115():125-31. PubMed ID: 24333909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the potential of lecithin/chitosan nanoparticles in enhancement of antihypertensive efficacy of hydrochlorothiazide.
    Chadha R; Bhandari S; Kataria D; Gupta S; Singh Jain D
    J Microencapsul; 2012; 29(8):805-12. PubMed ID: 22681125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies.
    Hädrich G; Monteiro SO; Rodrigues MR; de Lima VR; Putaux JL; Bidone J; Teixeira HF; Muccillo-Baisch AL; Dora CL
    Drug Dev Ind Pharm; 2016; 42(7):1165-73. PubMed ID: 26571009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induction and anti-cancer activity of LeciPlex formulations.
    Dhawan VV; Joshi GV; Jain AS; Nikam YP; Gude RP; Mulherkar R; Nagarsenker MS
    Cell Oncol (Dordr); 2014 Oct; 37(5):339-51. PubMed ID: 25204961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin.
    Senyiğit T; Sonvico F; Barbieri S; Ozer O; Santi P; Colombo P
    J Control Release; 2010 Mar; 142(3):368-73. PubMed ID: 19932722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin.
    Takahashi M; Uechi S; Takara K; Asikin Y; Wada K
    J Agric Food Chem; 2009 Oct; 57(19):9141-6. PubMed ID: 19757811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin.
    Chuah AM; Kuroiwa T; Ichikawa S; Kobayashi I; Nakajima M
    J Food Sci; 2009; 74(1):N1-8. PubMed ID: 19200109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of quercetin-loaded lipid liquid crystalline systems.
    Linkevičiūtė A; Misiūnas A; Naujalis E; Barauskas J
    Colloids Surf B Biointerfaces; 2015 Apr; 128():296-303. PubMed ID: 25701115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside.
    Zhang X; Lü S; Han J; Sun S; Wang L; Li Y
    Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis.
    Camuesco D; Comalada M; Concha A; Nieto A; Sierra S; Xaus J; Zarzuelo A; Gálvez J
    Clin Nutr; 2006 Jun; 25(3):466-76. PubMed ID: 16698151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene glycol) hydroxystearate-based nanosized emulsions: effect of surfactant concentration on their formation and ability to solubilize quercetin.
    Dora CL; Silva LF; Putaux JL; Nishiyama Y; Pignot-Paintrand I; Borsali R; Lemos-Senna E
    J Biomed Nanotechnol; 2012 Apr; 8(2):202-10. PubMed ID: 22515071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A facile route for creating "reverse" vesicles: insights into "reverse" self-assembly in organic liquids.
    Tung SH; Lee HY; Raghavan SR
    J Am Chem Soc; 2008 Jul; 130(27):8813-7. PubMed ID: 18543921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study.
    Hassan DH; Abdelmonem R; Abdellatif MM
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30347876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z; Lv H; Zhou J
    Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.